Name: ANIK: Anika Therapeutics Inc. Latest Stock Price, Analysis, News and Trading Ideas
Creator: Stocktwits

SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is surging following a blockbuster earnings report that showcased nearly 100% revenue growth and explosive U.S. commercial adoption, further fueling community debates over the company's valuation versus its role in the critical AI infrastructure value chain. Investors are closely monitoring whether the stock can sustain this momentum as the community shifts from fierce debate over short positions to high-conviction discussions about long-term enterprise AI dominance.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is facing intense investor debate following an announcement to exchange convertible debt for common stock, a move perceived by many as dilutive but interpreted by others as a strategic effort to improve the balance sheet for future acquisitions. The community remains deeply divided, with bulls viewing the pullback as an opportunity for long-term positioning and potential institutional accumulation, while bears highlight persistent concerns regarding management's vision and the lack of short-term shareholder returns.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is currently trending as investors focus on an upcoming earnings report that could signal a critical turnaround for the company following its recent ad revenue growth and subscription service expansion. Community sentiment remains polarized, with many traders actively discussing the stock's potential for a significant squeeze or re-rating, while others debate the long-term impact of its hardware investments and ongoing leadership concerns.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors brace for the final readout of its Phase 3 REGAL trial, with community sentiment driven by a mix of buyout speculation, institutional stake building by firms like Citigroup, and intense debate over the timing of the 80th survival event. Long-term supporters are highlighting the potential curative nature of the galinpepimut-S treatment, while active discourse remains focused on navigating the stock's volatility ahead of expected corporate catalysts.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors rotate into healthcare, driven by its dominant GLP-1 obesity and diabetes franchise and expectations for a guidance raise at the upcoming earnings report. The community remains focused on the company's sustained growth trajectory, its role as a defensive leader in biotech, and its aggressive expansion into neuroscience through high-profile M&A activity.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is trending after announcing a five-year, $335 million strategic storage agreement with CoreWeave, a move the community views as strong validation of the company's role in the AI infrastructure stack. Investors are actively debating the potential for an institutional re-rating and assessing the stock's high volatility, while others speculate on the possibility of a capital raise following the sharp price increase.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is currently facing intense selling pressure and community frustration as the price hovers near multi-year lows, leading to a polarizing debate among investors. While some view the current valuation as an attractive long-term entry point given the chain's institutional adoption and real-world utility, many traders are actively shorting the asset, citing weak buying pressure and a disconnect from the broader cryptocurrency market's performance.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies (VOYG) is trending following a strong quarterly earnings report that featured a record backlog and revenue guidance raised above analyst expectations, fueling community enthusiasm despite ongoing questions regarding long-term profitability. Investors are closely monitoring the company's ability to capitalize on defense modernization and space infrastructure contracts, with social sentiment reflecting a mix of excitement over recent growth and active debate regarding its valuation.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng is currently trending as investors weigh its aggressive expansion into humanoid robotics, robotaxis, and global markets against the persistent downward pressure affecting Chinese EV stocks. While the community remains divided between those betting on the company's long-term potential as a physical AI platform and those frustrated by its volatile stock performance, sentiment is heavily fueled by upcoming product launches and high-stakes developments in autonomous mobility.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnival Corp is trending as investors weigh strong travel demand and record bookings against the impact of rising fuel costs and geopolitical tensions in the Middle East ahead of its earnings report. The community is actively debating the stock's fundamental valuation compared to industry peers, with many traders closely monitoring oil price fluctuations and shipping route disruptions in the Strait of Hormuz for directional clues.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These 2 Biotech Stocks Hit New 52-Week Highs Today – And CORT Clocked Its Best Day In Nearly 16 Months

Equity

Corcept Therapeutics and Anika Therapeutics received Wall Street support after reporting strong second-quarter results and sharply raising their full-year 2026 outlook.

Anika Therapeutics (NASDAQ:ANIK) Director John Henneman III Buys 5,000 Shares

Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) Director John Henneman III acquired 5,000 shares of the stock in a transaction on Friday, May 1st. The shares were acquired at an average price of $14.66 per share, with a total value of $73,300.00. Following the transaction, the director...

Anika Therapeutics (NASDAQ:ANIK) CEO Stephen Griffin Purchases 12,200 Shares

Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) CEO Stephen Griffin purchased 12,200 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The shares were bought...

Anika Therapeutics (NASDAQ:ANIK) CEO Purchases $149,938.00 in Stock

Anika Therapeutics Inc. (NASDAQ:ANIK - Get Free Report) CEO Stephen Griffin bought 12,200 shares of the firm's stock in a transaction on Thursday, April 30th. The stock was purchased at an average...

Anika Therapeutics (NASDAQ:ANIK) Releases Earnings Results, Misses Expectations By $0.17 EPS

Anika Therapeutics (NASDAQ:ANIK - Get Free Report) posted its quarterly earnings data on Wednesday. The biotechnology company reported ($0.24) EPS for the quarter, missing analysts' consensus...

Anika Therapeutics Q1 Earnings Call Highlights

Anika Therapeutics (NASDAQ:ANIK) reported first-quarter 2026 results highlighting continued momentum in its commercial channel, progress in its hyaluronic acid (HA)-based product pipeline, and early...

Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above Two Hundred Day Moving Average - Time to Sell?

Anika Therapeutics (NASDAQ:ANIK) Stock Price Passes Above Two Hundred Day Moving Average - Time to Sell...

Anika Therapeutics (NASDAQ:ANIK) Stock Crosses Above 200 Day Moving Average - Should You Sell?

Anika Therapeutics (NASDAQ:ANIK) Stock Price Crosses Above Two Hundred Day Moving Average - Time to Sell...

Anika Therapeutics (NASDAQ:ANIK) Share Price Passes Above 200 Day Moving Average   - What's Next?

Anika Therapeutics (NASDAQ:ANIK) Stock Passes Above 200 Day Moving Average - What's Next...

Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above 200-Day Moving Average   - Time to Sell?

Anika Therapeutics (NASDAQ:ANIK) Share Price Crosses Above 200-Day Moving Average - Here's Why...

$ANIK Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.25 up 189.29% YoY
• Reported revenue of $32.61M up 15.56% YoY
• Anika Therapeutics, Inc. is raising its full-year 2026 revenue growth guidance to 5% to 10% and its adjusted EBITDA margin outlook to 13% to 17% for the fiscal year.

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company's main focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and its products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Anika Therapeutics Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ANIKAnika Therapeutics Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest ANIK News